Foresite Capital Opportunity Management V’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$3.48M Hold
2022
Q2
$3.68M Hold
2022
Q1
$3.28M Hold
2021
Q4
$5.17M Buy